Niger vs Rwanda: Population requiring preventive chemotherapy for schistosomiasis
Niger
5.10 million
in 2024
Rwanda
5.47 million
in 2024
Niger rank
16th
Rwanda rank
14th
Population requiring preventive chemotherapy for schistosomiasis over time
- Niger
- Rwanda
How they compare
Rwanda currently reports 5.47 million against 5.10 million in Niger, a difference of 369,650.
That makes Rwanda's figure about 1.1 times Niger's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Niger ahead.
Niger ranks 16th and Rwanda ranks 14th of 52 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Niger | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.02 million | 1.64 million | 3.37 million | Niger |
| 2020s | 8.69 million | 4.32 million | 4.37 million | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Niger or Rwanda?
- Rwanda, at 5.47 million against 5.10 million in Niger as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Niger and Rwanda?
- 369,650, with Rwanda ahead.
- How many years of comparable data are there for Niger and Rwanda?
- 15 years are reported by both, from 2010 to 2024.
- How do Niger and Rwanda rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Niger ranks 16th and Rwanda ranks 14th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.